Katrina de Romana
Primary Care · Castle Rock, CONPI 1679751267
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 34.1% of the total. Reporting peaked in 2022 at $788 and has fallen 96.2% since, to $30 in 2025.
Across 94 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$632
- Alkermes, Inc.$342
- Takeda Pharmaceuticals U.S.A., Inc.$81
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
- Otsuka America Pharmaceutical, Inc.$72
- Amgen$71
- plus $576 from 18 others
What the payments were for
- Food & beverage$1,852100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $632 |
| Alkermes, Inc. | 17 | $342 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Amgen | 4 | $71 |
| Indivior Inc. | 3 | $66 |
| Johnson & Johnson | 3 | $59 |
| Lilly USA, LLC | 4 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $51 |
| Neurocrine Biosciences, Inc. | 2 | $43 |
| Lucid Diagnostics Inc. | 2 | $39 |
| Tempus AI, Inc | 1 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $26 |
| Edwards Lifesciences | 1 | $26 |
| Pfizer | 2 | $25 |
| Corium, LLC | 1 | $24 |
| Bausch Health US, LLC | 1 | $24 |
| Nevro Corp. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| GSK | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,857 in reported general payments places this provider in the 85th percentile of 112 primary care providers in Colorado.
Other primary care in Castle Rock
- Kendra PayneCastle Rock$22K
- Laura CarlsenLittleton$22K
- Kaitlin KrausDenver$16K
- Emily WillmannThornton$4K
- Tracy RasmussenParker$4K
- Linda MyersGrand Junction$4K
- Kathryn PalmerGreeley$4K
- Leah BrownFort Morgan$3K
- Diana Rodriguez OrtizAurora$2K
- Amanda FadenrechtPueblo West$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.